References
- Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771–776. doi:10.1097/wco.0000000000000730
- Goutman SA, Hardiman O, Al-Chalabi A, et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21(5):465–479. doi:10.1016/s1474-4422(21)00414-2
- Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617–628. doi:10.1038/nrneurol.2013.203
- Feldman EL, Goutman SA, Petri S, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400(10360):1363–1380. doi:10.1016/s0140-6736(22)01272-7
- Factor-Litvak P, Al-Chalabi A, Ascherio A, et al. Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(Suppl 1):33–43. doi:10.3109/21678421.2013.778565
- Hardiman O, Al-Chalabi A, Brayne C, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg. 2017;88(7):557–563. doi:10.1136/jnnp-2016-314495
- Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/clep.S179083
- Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
- Statistics Denmark. Available from: https://m.statbank.dk/Data. Accessed Aug 16, 2023.
- European Medicines Agency. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/rilutek#authorisation-details-section. Accessed Aug 17, 2023.
- Health DNBo; 2024. Available from: https://www.sst.dk/da/fagperson/sundhedsvaesenets-rammer-og-uddannelser/specialeplaner-for-sygehusvaesnet/gaeldende-specialeplan/specialeplan-for-neurologi. Accessed September 4, 2024.
- Medicin DSfAoI. Available from: https://dasaim.dk/guides/rekommandationer-for-intensiv-terapi/. Accessed September 4, 2024.
- Nickelsen T. Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger. 2002;164:33–37.
- Henriksen DP, Rasmussen L, Hansen MR, Hallas J, Pottegård A. Comparison of the five Danish regions regarding demographic characteristics, healthcare utilization, and medication use--A descriptive cross-sectional study. PLoS One. 2015;10(10):e0140197. doi:10.1371/journal.pone.0140197
- de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497–503. doi:10.1016/j.clinph.2007.09.143
- Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124:96–107. doi:10.1016/0022-510X(94)90191-0
- Pugdahl K, Camdessanché JP, Cengiz B, et al. Gold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis. Clin Neurophysiol. 2021;132(12):3183–3189. doi:10.1016/j.clinph.2021.08.014
- Shefner JM, Al-Chalabi A, Baker MR, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975–1978. doi:10.1016/j.clinph.2020.04.005
- Kioumourtzoglou M-A, Seals RM, Himmerslev L, Gredal O, Hansen J, Weisskopf MG. Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population. Amyotrophic Lateral Scler Frontotemporal Degener. 2015;16(3–4):224–229. doi:10.3109/21678421.2014.988161
- Palese F, Pisa FE. Validation of discharge diagnosis coding for amyotrophic lateral sclerosis in an Italian regional healthcare database. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(5–6):428–434. doi:10.1080/21678421.2020.1752245
- Pisa FE, Verriello L, Deroma L, et al. The accuracy of discharge diagnosis coding for Amyotrophic Lateral Sclerosis in a large teaching hospital. Eur J Epidemiol. 2009;24(10):635–640. doi:10.1007/s10654-009-9376-1
- Beghi E, Logroscino G, Micheli A, et al. Validity of hospital discharge diagnoses for the assessment of the prevalence and incidence of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2(2):99–104. doi:10.1080/146608201316949541
- Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323–337. doi:10.1016/j.jclinepi.2004.10.012
- Loong TW. Understanding sensitivity and specificity with the right side of the brain. BMJ. 2003;327(7417):716–719. doi:10.1136/bmj.327.7417.716
- Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ. 2003;326(7379):41–44. doi:10.1136/bmj.326.7379.41
- Schneeweiss S. Understanding secondary databases: a commentary on ”Sources of bias for health state characteristics in secondary databases”. J Clin Epidemiol. 2007;60(7):648–650. doi:10.1016/j.jclinepi.2006.10.019